Want to see NZ:AFT full AI Analyst Report?
AFT Pharmaceuticals Ltd. (AFT) Revenue
AFT Pharmaceuticals Ltd. Revenue
AFT Pharmaceuticals Ltd. had a revenue of 139.76M in the quarter ending Mar 31, 2026, with 21.59%. This bring the company's revenue in the last twelve months to 254.71M, Increased 7.81%. In the fiscal year ending Mar 31, 2026, AFT Pharmaceuticals Ltd. had annual revenue of 254.71M with 23.95% growth.
- Revenue (ttm)
- 254.71M
- Revenue Growth
- 22.44%
- P/S Ratio
- 1.91
- Revenue/Employee
- NZD 2,021,468
- Employees
- 126
- Market Cap
- NZD 487.67M
Revenue Chart
AFT Pharmaceuticals Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 254.71M | 49.21M | 23.95% |
| Mar 31, 2025 | 205.49M | 10.08M | 5.16% |
| Mar 31, 2024 | 195.41M | 39.59M | 25.41% |
| Mar 31, 2023 | 155.82M | 25.99M | 20.01% |
| Mar 31, 2022 | 129.83M | 16.97M | 15.04% |
| Mar 31, 2021 | 112.86M | 7.62M | 7.24% |
| Mar 31, 2020 | 105.24M | 20.37M | 24.00% |
| Mar 31, 2019 | 84.87M | 4.99M | 6.25% |
| Mar 31, 2018 | 79.88M | 10.84M | 15.69% |
| Mar 31, 2017 | 69.05M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.